|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.900 EUR | +8.15% |
|
+72.50% | +298.84% |
| 07-06 | Carvolix Presents Clinical Data on TAVIPILOT Platform At New York Valves 2026 | CI |
| 06-24 | French Medical Technology Company Carvolix Plans EUR10 Million Share Offering | MT |
Company Valuation: Carvolix
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 32.61 | 63.01 | 55 | 467.3 | 467.3 | - |
| Change | - | 93.22% | -12.73% | 749.78% | 0% | - |
| Enterprise Value (EV) 1 | 32.61 | 80 | 71.4 | 495.1 | 520 | 552.5 |
| Change | - | 145.32% | -10.76% | 593.5% | 5.03% | 6.24% |
| P/E | - | -3.42x | -3.29x | -15.6x | -15x | -14.5x |
| PBR | - | 1.81x | 1.75x | 15x | 82.1x | -27.3x |
| PEG | - | - | 0.1x | -1.94x | -4.24x | -3.96x |
| Capitalization / Revenue | - | - | 11.8x | - | 295x | 38x |
| EV / Revenue | - | - | 15.3x | - | 329x | 44.9x |
| EV / EBITDA | - | -5.75x | -5.14x | -29.6x | -18.6x | -18.5x |
| EV / EBIT | - | -4.85x | -4.3x | -24.5x | -16.8x | -17x |
| EV / FCF | - | -6.1x | -5.49x | -26.1x | -13x | -13.4x |
| FCF Yield | - | -16.4% | -18.2% | -3.83% | -7.7% | -7.45% |
| Dividend per Share 3 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 3 | - | -0.54 | -0.41 | -0.4429 | -0.4586 | -0.4754 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | 4.669 | - | 1.583 | 12.3 |
| EBITDA 1 | - | -13.91 | -13.9 | -17.16 | -27.95 | -29.89 |
| EBIT 1 | - | -16.49 | -16.62 | -19.68 | -30.92 | -32.48 |
| Net income 1 | -16.61 | -16.77 | -16.74 | -28.8 | -33.13 | -34.68 |
| Net Debt 1 | - | 16.99 | 16.4 | 27.81 | 52.69 | 85.13 |
| Reference price 3 | 1.680 | 1.845 | 1.350 | 6.900 | 6.900 | 6.900 |
| Nbr of stocks (in thousands) | 18,164 | 30,899 | 39,348 | 59,244 | 59,244 | - |
| Announcement Date | 3/30/23 | 4/25/24 | 4/24/25 | 3/19/26 | - | - |
1EUR in Million2USD in Million3EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.58x | - | -29.61x | -.--% | 467M | |
| 63.48x | 7.59x | 40.11x | -.--% | 12.51B | |
| 30.38x | 6.28x | 17.06x | 1.24% | 5.87B | |
| 19.93x | 1.86x | 9.82x | 2.43% | 5.87B | |
| 22.87x | 1.15x | 7.14x | -.--% | 4.29B | |
| 28.2x | 8.42x | 21.42x | 0.71% | 4.26B | |
| 16.7x | 2.93x | 14x | 3.91% | 3.83B | |
| -18.8x | 467.88x | -81.24x | -.--% | 1.94B | |
| -10.22x | 2.37x | -10.37x | - | 1.89B | |
| 20.06x | 2.39x | 9.64x | 2.17% | 1.56B | |
| Average | 15.70x | 55.65x | -0.20x | 1.16% | 4.25B | |
| Weighted average by Cap. | 31.54x | 26.43x | 15.51x | 1.06% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CVX Stock
- Valuation Carvolix
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
